125 related articles for article (PubMed ID: 19214032)
21. Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and response to treatment.
Jehan F; Gaucher C; Nguyen TM; Walrant-Debray O; Lahlou N; Sinding C; Déchaux M; Garabédian M
J Clin Endocrinol Metab; 2008 Dec; 93(12):4672-82. PubMed ID: 18827005
[TBL] [Abstract][Full Text] [Related]
22. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
Alon U; Chan JC
J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
[TBL] [Abstract][Full Text] [Related]
23. Craniosynostosis as the Presenting Feature of X-linked Hypophosphatemic Rickets.
Vakharia JD; Matlock K; Taylor HO; Backeljauw PF; Topor LS
Pediatrics; 2018 Apr; 141(Suppl 5):S515-S519. PubMed ID: 29610183
[TBL] [Abstract][Full Text] [Related]
24. Epidermal nevus syndrome associated with hypophosphatemic rickets.
Moreira AI; Ferreira G; Santos M; Baptista A; Ferreira EO
Dermatol Online J; 2010 Sep; 16(9):14. PubMed ID: 20875335
[TBL] [Abstract][Full Text] [Related]
25. Unusual cases of hyperparathyroidism.
Vázquez-Quintana E; Haddock L; Aguiló F; Sotomayor R; Ramírez M; Vázquez-Plard J; Rabell V; Pagán Sáez H
P R Health Sci J; 1995 Sep; 14(3):227-32. PubMed ID: 8588025
[TBL] [Abstract][Full Text] [Related]
26. [Gene mutation analysis of X-linked hypophosphatemic rickets].
Song Y; Ma HW; Li F; Hu M; Ren S; Yu YF; Zhao GJ
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):928-31. PubMed ID: 24229582
[TBL] [Abstract][Full Text] [Related]
27. Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets.
Savio RM; Gosnell JE; Posen S; Reeve TS; Delbridge LW
Arch Surg; 2004 Feb; 139(2):218-22. PubMed ID: 14769584
[TBL] [Abstract][Full Text] [Related]
28. Urinary calcium to creatinine ratio: a potential marker of secondary hyperparathyroidism in patients with vitamin D-dependent rickets type 1A.
Miyai K; Onishi T; Kashimada K; Hasegawa Y
Endocr J; 2015; 62(1):61-8. PubMed ID: 25284246
[TBL] [Abstract][Full Text] [Related]
29. Cortical and trabecular bone density in X-linked hypophosphatemic rickets.
Cheung M; Roschger P; Klaushofer K; Veilleux LN; Roughley P; Glorieux FH; Rauch F
J Clin Endocrinol Metab; 2013 May; 98(5):E954-61. PubMed ID: 23533226
[TBL] [Abstract][Full Text] [Related]
30. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
Zucchi C
Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
[No Abstract] [Full Text] [Related]
31. [Mid-third femoral shaft fracture in a patient with hypophosphatemic rickets treated with a locking centromedullary nail].
Juárez Jiménez HG; Mier Cisneros R; Peralta Cruz S
Acta Ortop Mex; 2009; 23(4):193-6. PubMed ID: 19960655
[TBL] [Abstract][Full Text] [Related]
32. Successful management of tertiary hyperparathyroidism associated with hypophosphataemic rickets in an adult.
Anagnostis P; Vamvakidis K; Tournis S
J Musculoskelet Neuronal Interact; 2019 Sep; 19(3):370-373. PubMed ID: 31475945
[TBL] [Abstract][Full Text] [Related]
33. Hyperparathyroidism in Patients With X-Linked Hypophosphatemia.
Lecoq AL; Chaumet-Riffaud P; Blanchard A; Dupeux M; Rothenbuhler A; Lambert B; Durand E; Boros E; Briot K; Silve C; Francou B; Piketty M; Chanson P; Brailly-Tabard S; Linglart A; Kamenický P
J Bone Miner Res; 2020 Jul; 35(7):1263-1273. PubMed ID: 32101626
[TBL] [Abstract][Full Text] [Related]
34. Tertiary hyperparathyroidism attributable to long-term oral phosphate therapy.
McHenry CR; Mostafavi K; Murphy TA
Endocr Pract; 2006; 12(3):294-8. PubMed ID: 16772203
[TBL] [Abstract][Full Text] [Related]
35. The journey from vitamin D-resistant rickets to the regulation of renal phosphate transport.
Levine BS; Kleeman CR; Felsenfeld AJ
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1866-77. PubMed ID: 19808223
[TBL] [Abstract][Full Text] [Related]
36. Treatment of hypophosphataemic rickets in children remains a challenge.
Nielsen LH; Rahbek ET; Beck-Nielsen SS; Christesen HT
Dan Med J; 2014 Jul; 61(7):A4874. PubMed ID: 25123121
[TBL] [Abstract][Full Text] [Related]
37. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL
J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
[TBL] [Abstract][Full Text] [Related]
38. Normal growth and muscle dysfunction in X-linked hypophosphatemic rickets associated with a novel mutation in the PHEX gene.
Makras P; Hamdy NA; Kant SG; Papapoulos SE
J Clin Endocrinol Metab; 2008 Apr; 93(4):1386-9. PubMed ID: 18252791
[TBL] [Abstract][Full Text] [Related]
39. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
Živičnjak M; Schnabel D; Staude H; Even G; Marx M; Beetz R; Holder M; Billing H; Fischer DC; Rabl W; Schumacher M; Hiort O; Haffner D;
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957
[TBL] [Abstract][Full Text] [Related]
40. PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia.
Blydt-Hansen TD; Tenenhouse HS; Goodyer P
Pediatr Nephrol; 1999 Sep; 13(7):607-11. PubMed ID: 10460513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
